nav-left cat-right
cat-right

NIH awarded nine awards for NCATS’ New Therapeutic...

NIH awarded $12.7 million for nine awards for NCATS’ New Therapeutic Uses program which matches academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients. Christopher Austin comments “These awards will support cooperative agreements with nine different academic research groups that are going to conduct pre-clinical validation — clinical feasibility studies...

J&J innovation team sets up international col...

Johnson & Johnson ($JNJ) has spent hundreds of millions of dollars in a so-far failed effort to develop a late-stage biologic that could be used to treat Alzheimer’s. And it’s now prepared to spend hundreds of millions more as it goes back to the drawing board to explore the molecular underpinnings of the disease in an attempt to find new therapies that promise to thwart the disease before it cripples the...

BioFocus and University of Bristol enter drug disc...

Saffron Walden and Bristol, UK; 16 July 2010 – BioFocus and the University of Bristol today announced a new drug discovery collaboration aimed at developing treatments for chronic pain associated with diabetes (diabetic neuropathic pain).  BioFocus will provide hit-to-lead and lead optimization services for a Wellcome Trust funded program at the University of Bristol.  Total contract value for BioFocus could...

NIH Prolongs Compound-Management Arrangement with ...

NIH has extended its agreement with Galapagos’ service division, BioFocus, for the operation of the Molecular Libraries Small Molecule Repository (MLSMR) through December 2012. Galapagos will thus be eligible to receive up to $8.6 million over the course of the two-year extension. The NIH MLSMR collects samples for high-throughput biological screening and distributes them to the NIH Molecular Libraries Screening Center...

Aquapharm and AMRI Enter into a Novel Marine Chemi...

Aquapharm Biodiscovery, a leading marine biotechnology company, announced today it has signed a research agreement with Albany Molecular Research  to identify novel drug-like compounds and scaffolds with anti-microbial and anti-inflammatory activity from Aquapharm’s marine natural products library derived from its extensive collection of marine micro-organisms.Under the terms...

Asterand Signs Agreement with Amylin Pharmaceutica...

Asterand plc /quotes/comstock/23s!e:atd (UK:ATD 13.25, 0.00, 0.00%) , a leading provider of human tissue and human tissue-based research services to pharmaceutical and biotechnology companies engaged in drug discovery, today announces that its subsidiary BioSeek, LLC, a pioneer in the application of predictive human biology to drug discovery, has signed a...
Page 5 of 31« First...34567...102030...Last »